| Literature DB >> 30191305 |
Alberto Modenese1, Fabriziomaria Gobba2.
Abstract
PURPOSE: Macular degeneration is a multi-factorial disease, leading cause of blindness for people over 50 years old in developed countries. To date, the knowledge on possible occupational factors involved in the development of the disease is scant.Entities:
Keywords: Blue light; Chemical exposure; Macular degeneration; Occupational exposure; Solar radiation; Ultraviolet radiation
Mesh:
Year: 2018 PMID: 30191305 PMCID: PMC6323067 DOI: 10.1007/s00420-018-1355-y
Source DB: PubMed Journal: Int Arch Occup Environ Health ISSN: 0340-0131 Impact factor: 3.015
Fig. 1Selection process of the reviewed studies
Main characteristics and results of the studies included in the systematic review on macular degeneration and exposure to occupational risk factors
| First author, year | Place | Subjects group/sample size ( | Occupational risk factor associated (if identified), MD subtype and severity (if provided) and MD frequency (if available), other relevant results of the study | Quality score (0–9) | |
|---|---|---|---|---|---|
| Retrospective/prospective | |||||
| Thapa, 2011 | Nepal | PtA/141 | SR-OW (based on job title) | 2 | |
| Njiric, 2007 | Croatia | PtA/6617 | SR-OW (based on job title) | 3 | |
| Vojnikovic 2007 | Croatia | Wo/1371 | SR-OW (based on job title) | 2 | |
| Klein, 2001 | US | GP(A)/3672 | 5-years incidence of early stage MD = 17% for waiters; 13% for cooks; 21% for bartenders; 13% for cleaning services personnel | 7 | |
| Bressler, 1995 | US | Wo/483 | SR-OW (based on job title): 5-years incidence in Maritime workers = Grade 3 MD*: age adjusted 9% (30–39 ys: 7%; 40–49 ys: 4%; 50–59 ys: 7%; 60–69 ys: 14%; >70 ys: 26%) | 8 | |
| Cross sectional/case–control | |||||
| Saadat, 2012 | Iran | PtA/223 | SR-OW (based on job title): polymorphism of gene XRCC7 in OW with exudative MD: OR 3.1 (CI 95%, 1.04–9.4; | 3 | |
| Plestina-Borjan, 2007 | Croatia | GP(A)/623 | SR-OW (based on job title): 113 maritime workers and farmers with SR exposure > 8 h/day had MD, | 3 | |
| Hyman, 1983 | US | PtA/465 | Occupational chemical exposure (based on questionnaire investigation), history of: OR* = 4.2 (1.1–15.2). Considering only males: OR* = 3.8 (1.0–14.5) | 7 | |
| Cross sectional | |||||
| Schick, 2016 | Europe | PtA/3701 | Prevalence = 20.3% early MD*; 31.9% late MD* | 8 | |
| Park, 2014 | South Korea | GP(A)/14352 | Age weighted prevalence: 6.6% for all forms; 6% early MD*; 0.6% all late MD* forms; 0.5% wet late MD*; 0.1% geographic atrophy* | 8 | |
| Caljkusic-Mance, 2010 | Croatia | PtA/60 | Among the MD cases, 75% dry (atrophic) MD, 25% wet (neovascular) MD | 3 | |
| Fletcher, 2008 | Europe | GP(A)/4753 | Prevalence of MD according to severity* in subjects > 65 years: grade 4 MD (neovascular) = 2.3%; grade 4 (geographic atrophy) = 1%; early MD (grade 1 + 2 + 3) = 45.9%; grade 1 = 36.5%; grade 2 = 10.1%; grade 3 = 2.5% | 9 | |
| Taylor, 1990 | US | Wo/782 | MD prevalence in maritime workers according to severity = 27.6% grade 1; 18.9%grade 2; 12.0% grade 3; 1.2% grade | 8 | |
GP(A) general population (adults), IW indoor workers, MD macular degeneration, OR odd ratio (confidence interval 95%), OW outdoor workers, PtA patients (adults), n.a. no association, n. s. not significant, SR solar radiation exposure, Wo workers
Results of the quality assessment of the studies included in the systematic review on macular degeneration and exposure to occupational risk factors
(adapted from Poole et al. 2017)
| First author, year | Selection bias domain (max 4 points) | Comparability domain (max 3 points) | Outcome domain (max 2 points) | Total score (0–9) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Sample representative | > 1 site studied | Standard exposure | Standard outcome | Several confounders | Some confounders | Controls | Statistics appropriate | Conclusions justified | ||
| Retrospective/prospective | ||||||||||
| Thapa, 2011 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2 |
| Njiric, 2007 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 3 |
| Vojnikovic, 2007 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 2 |
| Klein, 2001 | 1 | 1 | 0 | 1 | 0 | 1 age, sex | 1 | 1 | 1 | 7 |
| Bressler, 1995 | 1 | 1 | 1 | 1 | 0 | 1 age | 1 | 1 | 1 | 8 |
| Cross sectional case–control | ||||||||||
| Saadat, 2012 | 0 | 0 | 0 | 1 | 0 | 1 age | 1 | 0 | 0 | 3 |
| Plestina-Borjan, 2007 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 3 |
| Hyman, 1983 | 1 | 1 | 0 | 1 | 0 | 1 age, sex | 1 | 1 | 1 | 7 |
| Cross sectional | ||||||||||
| Schick, 2016 | 1 | 1 | 0 | 1 | 2 age, sex, smoking | 0 | 1 | 1 | 1 | 8 |
| Park, 2014 | 1 | 1 | 0 | 1 | 2 age, sex, smoking | 0 | 1 | 1 | 1 | 8 |
| Caljkusic-Mance, 2010 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 3 |
| Fletcher, 2008 | 1 | 1 | 1 | 1 | 2 age, sex, smoke, diabetes, cardio-vascular disease, education, retinol, aspirin, cholesterol | 0 | 1 | 1 | 1 | 9 |
| Taylor, 1990 | 1 | 1 | 1 | 1 | 0 | 1 (age) | 1 | 1 | 1 | 8 |